SURG: financial statements from SEC — TradeAlmanac

SURG

SurgePays, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31 Dec 2025	31 Dec 2024
Revenue	57M	61M
Cost of revenue	68M	75M
Selling, general and administrative	20M	27M
Operating expenses	91M	103M
Operating income	−34M	−42M
Pre-tax income	−36M	−43M
Income tax	—	3M
Net income	−36M	−46M
Earnings per share	−1.80	−2.39
Earnings per share, diluted	−1.80	−2.39
Weighted average shares	20M	19M
Weighted average shares, diluted	20M	19M

Balance sheet

Metric	31 Mar 2026	31 Dec 2025	30 Sept 2025	30 Jun 2025	31 Mar 2025	31 Dec 2024	31 Oct 2024	30 Sept 2024
Cash and equivalents	2M	2M	3M	4M	5M	12M	—	14M
Short-term investments	—

Cash flow

Metric	31 Dec 2025	31 Dec 2024
Operating cash flow	−21M	−21M
Depreciation and amortisation	859,970	942,450
Capital expenditure	18,590	518,189
Investing cash flow	−18,590	−3M
Financing cash flow	11M	22M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator